SBIR/STTR Research Award

DESTRUCTION OF AIR-BORNE PATHOGENIC BACTERIA

Award identifier eaccf5f555382f9fbcab2a3e14844ec76a7cf9d61c6d24a816b53a799a1121c2Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
KSE, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
XSP4KY3W1KA5
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The objective of this research project is to establish the technical and economic feasibility of a novel photocatalytic technology to inactivate air-borne Bacillus anthracis (anthrax), using representative surrogate bacterial spores, B. cereus. The technology is to be incorporated into circulating air ducts of buildings, providing protection against introduction of anthrax bacteria into central air systems by a terrorist act. There is also a need for a technology which can inactivate a broad range of such pathogens, since bioengineering could lead to modified anthrax spores. Such a broad acting technology could also find immediate applicability in curing "sick building" syndrome, by destroying other microorganisms and organic vapors in indoor air. KSE, Inc. has already developed a new class of photocatalysts, orders of magnitude more active for organic compound oxidation than the traditional titania. This new class of photocatalysts will be adapted for use in anthrax spore destruction, in cooperation with the University of Massachusetts, Department of Microbiology. The program will utilize photocatalyst composition studies to tailor a superior photocatalyst for this application, reactor studies of the bactericidal efficacy of the new photocatalysts, and a competitive cost analysis of the technology relative to other alternatives for maintenance of indoor air quality. The commercial applications will provide an air purification technology with broad bactericidal activity, particularly useful for anthrax spores, bioengineered anthrax, and other pathogens, as well as common microorganisms contributing to a "sick building." It will thus provide a central defense strategy against the threat of introduction of lethal anthrax spores into central air systems, while also providing immediate commercial benefit through improvements of indoor air quality of commercial buildings by removing organic compounds and common microorganisms.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

68 SBIR/STTR records share this UEI (1983–2023). Reported award amounts total $14,305,697. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Energy, Environmental Protection Agency, National Science Foundation, Department of Defense, Department of Health and Human Services, Department of Agriculture

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.